Eric H. Rosenn earned a B.S. in Biochemistry from Binghamton University in 2019 and is currently pursuing graduate studies in Bioinformatics at New York University. He previously completed two years of preclinical medical education at Tel Aviv University. Before shifting toward translational computation and biotech-focused research, he accumulated more than five years of basic-science research experience, including laboratory work and other research activities across institutions including Binghamton University, Mount Sinai Medical Center, NYU Medical Center, the City College of New York, and Weill Cornell Medical Center. Rosenn began publishing academic research as a first author in 2023 and has since contributed to multiple research articles, book chapters, and conference presentations. His research interests have included infectious disease, bacteriology, the gut microbiome, and neurological disorders, with more recent work focusing on multi-omics technologies, computational biology, drug development, and quantitative modeling. He is also interested in scientific communication, ethical publishing practices, and bibliometrics. In 2026, he founded Biology & Molecular Medicine (BAMM), an independent open-access journal focused on biomedicine and biomedical technology, with a guiding mission of transparency and accessibility while actively supporting student and early-career researchers. He intends to pursue doctoral research at the interface of computational systems biology